Erfa Canada
Searchlight Pharma Inc. (Erfa Canada) is a Montreal-based specialty pharmaceutical company and the specialty pharma division of Apotex, commercializing and developing over 65 branded products across women's health, dermatology, allergy, neurology, pain management, and hospital specialty markets in Canada and through global partners.
- Company typePrivate
- Founded1998
- HeadquartersMontréal, Canada
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Erfa Canada does
Erfa Canada, legally operating as Searchlight Pharma Inc., is a Montreal-based specialty pharmaceutical company founded in 1998 that functions as the specialty pharmaceutical division of Apotex, a Canadian Global Health Company. The company executes in-house search, acquisition, commercialization, and focused development of specialty branded pharmaceuticals and healthcare products, managing a unified portfolio of over 65 commercial, partnered, and pipeline brands across six therapeutic areas: women's health, dermatology, allergy, neurology, pain management, and hospital specialty markets.
The business is organized around three interconnected product lines. Commercial Brands are products marketed directly by Searchlight in Canada; Partnered Brands are products introduced to patients in new global markets through a network of strategic partners; and Pipeline consists of innovative specialty products in development intended for future commercialization. The underlying commercial platform is a brand-acquisition-and-life-cycle-management model rather than a discovery-led R&D model, with therapeutic-area focus providing portfolio coherence.
Revenue mechanics are split between direct domestic commercialization in Canada (single-country) and a global channel/reseller model via strategic partners (international). Pricing is not publicly disclosed. End customers are patients across the six targeted therapeutic categories, accessed primarily through standard pharmaceutical distribution and prescription channels; the company itself does not disclose named enterprise buyers, headcount, or revenue, limiting external visibility into scale despite the 65+ brand footprint and global reach implied by the partner network.
Erfa Canada firmographics
Firmographics- Name
- Erfa Canada
- Legal name
- Searchlight Pharma Inc.
- Website
- https://eci2012.net
- Company type
- Private
- Founded year
- 1998
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Searchlight Pharma Inc. (Erfa Canada) is a Montreal-based specialty pharmaceutical company and the specialty pharma division of Apotex, commercializing and developing over 65 branded products across women's health, dermatology, allergy, neurology, pain management, and hospital specialty markets in Canada and through global partners.
- Ownership category
- akta.pro rank
Erfa Canada industry classification
Industry- Product category
- Specialty Pharmaceuticals
- NAICS
- Pharmaceutical Preparation Manufacturing (325412)
- SIC
- Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
- akta.pro primary industry
- Therapeutic Enzymes & Enzyme Replacement Therapies (ERT) (HLAAAAAK)
Keywords
Where Erfa Canada is headquartered
LocationHeadquarters
- HQ city
- Montréal
- HQ country
- Canada
- HQ region
- North America
Offices1 record
Markets served
Erfa Canada business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Personnel, Marketing or Sales, Operations, Technology or R&D
Distribution channels2 records
Marketing channels2 records
Erfa Canada product offering
Product offeringCore offering
Erfa Canada (Searchlight Pharma Inc.) is a Montreal-based specialty pharmaceutical manufacturer and wholesaler that executes search, acquisition, commercialization, and focused development of branded pharmaceutical and healthcare products. Its portfolio spans over 65 brands across women's health, dermatology, allergy, neurology, pain management, and hospital specialty markets, commercialized directly in Canada and through strategic partners globally.
Product overview
Searchlight Pharma operates as a specialty pharmaceutical company with a platform approach to brand acquisition, commercialization, and focused development. The company manages a unified portfolio of over 65 commercial, partnered, and pipeline brands across women's health, dermatology, allergy, neurology, pain management, and hospital specialty markets. The portfolio consists of three interconnected product lines: Commercial Brands (products marketed directly by Searchlight in Canada), Partnered Brands (products commercialized through global strategic partnerships), and Pipeline products (innovative products in development for future commercialization).
Differentiator
Problem solved
Functional benefit
Products and services
- Commercial Brands
Companies that use Erfa Canada
Customer profileSegments6 records
Ideal customer profiles2 records
Erfa Canada technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Erfa Canada partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- ApotexcoreSearchlight operates as the specialty pharmaceutical division of Apotex, a Canadian-based Global Health Company with a broad portfolio of generic, biosimilar, and innovative branded pharmaceutical products. This relationship provides Searchlight with access to Apotex's global distribution network and commercialization infrastructure.
Scale indicators1 record
Recent moves5 records
Expansion highlights4 records
Erfa Canada competitors and assessment
Company assessmentDirect peers
- Cipher Pharmaceuticals: Canadian specialty pharmaceutical company focused on acquiring and commercializing branded prescription products in dermatology and other specialty categories. Directly comparable as a Canadian-headquartered specialty pharma commercialization platform.
- Knight Therapeutics: Canadian specialty pharmaceutical company that acquires, in-licenses, and commercializes innovative branded products across similar therapeutic areas. Closely comparable business model to Searchlight/Erfa — specialty pharma platform with Canadian commercialization and international partner reach.
- HLS Therapeutics: Canadian specialty pharmaceutical company commercializing branded products in CNS, cardiovascular, and other specialty therapeutic areas. Comparable business model of in-licensing and commercializing specialty branded products in Canada with select international distribution.
Broad incumbents
- Bausch Health: Large Canadian-headquartered specialty pharmaceutical company with diversified branded specialty pharma, generics, and consumer health portfolios. Comparable as a Canadian specialty pharma incumbent across dermatology, neurology, and other specialty categories.
- Purdue Pharma: Specialty pharmaceutical company historically focused on branded prescription products in pain management and adjacent specialty areas. Comparable as a specialty pharma platform with branded prescription commercialization capabilities overlapping Searchlight/Erfa's pain management focus.
- Apotex: Parent company of Searchlight Pharma and broader Canadian global health company with generics, biosimilars, and innovative branded pharmaceuticals. While much larger and broader in scope, Apotex is directly comparable as the operating context for Searchlight/Erfa and a relevant peer for portfolio overlap.
- Mallinckrodt plc: Global specialty pharmaceutical company with hospital specialty, neurology, and branded prescription portfolios. Comparable as a specialty pharma platform with hospital channel presence overlapping Searchlight/Erfa's hospital specialty focus.
- Endo International: Global specialty pharmaceutical company focused on branded and generic pharmaceuticals across therapeutic areas including pain management, neurology, and hospital specialty. Comparable product mix in two of Searchlight/Erfa's stated core categories.
- Sun Pharmaceutical Industries: Large global specialty and generic pharmaceutical company with significant branded specialty presence across dermatology, neurology, and women's health. Comparable as a large-scale branded specialty pharma commercialization platform with broader geographic reach.
- Perrigo Company: Global consumer-focused specialty pharmaceutical company with significant branded and self-care product portfolios in dermatology, women's health, and specialty categories. Comparable as a portfolio-driven specialty pharma commercialization platform with overlapping therapeutic categories.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
Erfa Canada social profiles
Digital presenceErfa Canada financial estimates
Financial estimateRevenue estimate
Valuation estimate
Erfa Canada leadership team
Management profileNumber of profiles
Profiles1 record
Erfa Canada funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Erfa Canada M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Erfa Canada
What does Erfa Canada do?
Erfa Canada (Searchlight Pharma Inc.) is a Montreal-based specialty pharmaceutical manufacturer and wholesaler that executes search, acquisition, commercialization, and focused development of branded pharmaceutical and healthcare products. Its portfolio spans over 65 brands across women's health, dermatology, allergy, neurology, pain management, and hospital specialty markets, commercialized directly in Canada and through strategic partners globally.
Is Erfa Canada a public or private company?
Erfa Canada is a private company. It is classified as corporate owned and is currently operating.
When was Erfa Canada founded?
Erfa Canada was founded in 1998. It employs 11 to 50 people.
Where is Erfa Canada based?
Erfa Canada is headquartered in Montréal, Canada, in the North America region.
Who are Erfa Canada's main competitors?
Direct peers on record are Cipher Pharmaceuticals, Knight Therapeutics and HLS Therapeutics. Broad incumbents are Bausch Health, Purdue Pharma, Apotex, Mallinckrodt plc, Endo International, Sun Pharmaceutical Industries and Perrigo Company.
Does Erfa Canada have an API?
No public API is recorded for Erfa Canada.
What industry is Erfa Canada in?
Erfa Canada's product category is Specialty Pharmaceuticals. Its primary akta.pro industry code is HLAAAAAK, Therapeutic Enzymes & Enzyme Replacement Therapies (ERT). Its NAICS code is 325412 and its SIC code is 2834.